Skip to main content
TipRanks
Go Ultimate75% OFF

Redcare Pharmacy (SAE) AI Stock Analysis

2 Followers
CH:SAE

Redcare Pharmacy

(BX Swiss:SAE)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Revenue GrowthSustained revenue expansion shows that Redcare is increasing its commercial scale across online pharmacy and health products. A larger sales base can improve purchasing leverage, spread fixed logistics costs, and support continued investment in customer acquisition and fulfillment capacity.
Negative Factors
Persistent Net LossesRedcare remains loss-making despite its large revenue base, while operating profit is modest relative to sales. Persistent negative earnings constrain internally funded growth, weaken returns on shareholder capital, and leave the company more exposed if progress toward profitability stalls.

Redcare Pharmacy (SAE) vs. iShares MSCI Switzerland ETF (EWL)

-25%0%25%50%75%100%125%150%CH:SAE+118.96%EWL+12.16%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CHF 1.27B
Dividend Yield
―
Average Volume (3M)
81
Price to Earnings (P/E)
-39.3
Beta (1Y)
-0.14
Revenue Growth
16.86%
EPS Growth
4.21%
Country
Switzerland
Employees
2,163
Sector
Healthcare
Sector Strength
51
Industry
Medical - Distribution

Redcare Pharmacy Business Overview & Revenue Model

Company Description

Redcare Pharmacy N.V. manages and runs a network of digital pharmacies across Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. The company offers a comprehensive selection of healthcare products, including prescription medi...

Redcare Pharmacy Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CH:SAE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:COPDE:COP53NeutralEUR 1.47B43.424.19%1.78%――
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
DE:B8FKDE:B8FK48NeutralEUR 17.68M-1.50-110.30%―――
DE:GMEDE:GME45NeutralEUR 11.22M-14.76-4.38%4.85%1.58%-148.73%
DE:HPHADE:HPHA41NeutralEUR 96.38M-3.22200.64%―206.78%-13.94%

* Healthcare Sector Average

Performance Comparison

0%50%100%CH:SAEDE:B8FKDE:COPDE:GMEDE:HPHADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:SAE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:SAERedcare Pharmacy65.2535.45118.96%
DE:B8FKBiofrontera AG2.810.114.07%
DE:COPCompuGroup Medical27.454.1317.71%
DE:GMEGeratherm Medical2.13-1.12-34.38%
DE:HPHAHeidelberg Pharma AG2.07-0.90-30.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.